Hudson Therapeutics, US Subsidiary of Shaperon
Durham, United States (US) · Health and Medical
We built this page from public sources.
Do you work at Hudson Therapeutics, US Subsidiary of Shaperon?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
#biotechnology
#anti-inflammatory
#immunology
#atopic dermatitis
#inflammasome inhibitor
#alzheimer
#orphan disease
#nanobody
Hudson Therapeutics, US Subsidiary of Shaperon is a clinical-stage biotechnology company based in Durham, North Carolina, focused on developing innovative drugs for inflammatory and immunological diseases.Founded in February 2023 by Shaperon Inc., a KOSDAQ-listed biotech in Korea, and led by Dr.
Overview
Founded in February 2023 by Shaperon Inc., a KOSDAQ-listed biotech in Korea, and led by Dr. Shawn Y. Seong, Hudson Therapeutics, Inc. leverages a strategic approach to enhance therapeutic potential.
Our core strategy involves in-licensing promising assets, adding value through innovative development, and ultimately out-licensing them to maximize their commercialization. We are dedicated to enriching patients’ quality of life through advancements in anti-inflammatory and immunology therapies.
Contact Details
Durham, United States (US), 600 Park Office Dr
Founded
2023
Company Type
Public Limited Company
Employees
2-10
Categories
Keywords
#biotechnology
#anti-inflammatory
#immunology
#atopic dermatitis
#inflammasome inhibitor
#alzheimer
#orphan disease
#nanobody
Companies teams usually look at after Hudson Therapeutics, US Subsidiary of Shaperon
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.